Hartford Funds Management Co LLC Has $2.78 Million Stock Position in HCA Healthcare, Inc. $HCA

Hartford Funds Management Co LLC increased its holdings in HCA Healthcare, Inc. (NYSE:HCAFree Report) by 32.3% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 5,874 shares of the company’s stock after purchasing an additional 1,434 shares during the period. HCA Healthcare makes up 0.2% of Hartford Funds Management Co LLC’s investment portfolio, making the stock its 19th biggest holding. Hartford Funds Management Co LLC’s holdings in HCA Healthcare were worth $2,782,000 as of its most recent SEC filing.

Several other large investors also recently made changes to their positions in the stock. Nordea Investment Management AB boosted its stake in shares of HCA Healthcare by 11.2% in the 4th quarter. Nordea Investment Management AB now owns 1,084,590 shares of the company’s stock valued at $507,393,000 after purchasing an additional 108,849 shares in the last quarter. Nomura Asset Management Co. Ltd. lifted its holdings in HCA Healthcare by 6.2% during the 4th quarter. Nomura Asset Management Co. Ltd. now owns 64,237 shares of the company’s stock valued at $29,990,000 after purchasing an additional 3,724 shares during the last quarter. Hudson Bay Capital Management LP grew its stake in HCA Healthcare by 154.5% during the third quarter. Hudson Bay Capital Management LP now owns 4,693 shares of the company’s stock worth $2,000,000 after buying an additional 2,849 shares during the last quarter. Advisors Capital Management LLC raised its stake in shares of HCA Healthcare by 61.5% in the fourth quarter. Advisors Capital Management LLC now owns 6,836 shares of the company’s stock valued at $3,192,000 after acquiring an additional 2,604 shares during the last quarter. Finally, CWA Asset Management Group LLC grew its position in HCA Healthcare by 1,062.4% during the 4th quarter. CWA Asset Management Group LLC now owns 9,555 shares of the company’s stock worth $4,461,000 after acquiring an additional 8,733 shares during the last quarter. Institutional investors own 62.73% of the company’s stock.

HCA Healthcare Stock Performance

Shares of HCA stock opened at $390.81 on Tuesday. The firm’s 50 day moving average price is $396.68 and its two-hundred day moving average price is $459.73. The stock has a market cap of $86.70 billion, a PE ratio of 13.44, a PEG ratio of 1.29 and a beta of 1.12. HCA Healthcare, Inc. has a 52-week low of $330.00 and a 52-week high of $556.52.

HCA Healthcare (NYSE:HCAGet Free Report) last posted its quarterly earnings results on Friday, April 24th. The company reported $7.15 earnings per share for the quarter, missing analysts’ consensus estimates of $7.19 by ($0.04). The company had revenue of $19.11 billion during the quarter, compared to analyst estimates of $19.09 billion. HCA Healthcare had a net margin of 8.89% and a negative return on equity of 295.93%. The business’s revenue for the quarter was up 4.3% compared to the same quarter last year. During the same period last year, the company earned $6.45 EPS. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. As a group, sell-side analysts predict that HCA Healthcare, Inc. will post 30.07 earnings per share for the current fiscal year.

HCA Healthcare Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, June 30th. Stockholders of record on Tuesday, June 16th were paid a $0.78 dividend. The ex-dividend date of this dividend was Tuesday, June 16th. This represents a $3.12 dividend on an annualized basis and a dividend yield of 0.8%. HCA Healthcare’s dividend payout ratio is 10.73%.

Analysts Set New Price Targets

Several brokerages have recently commented on HCA. Royal Bank Of Canada decreased their target price on HCA Healthcare from $593.00 to $534.00 and set an “outperform” rating on the stock in a report on Monday, April 27th. Jefferies Financial Group reiterated a “buy” rating and set a $525.00 price target on shares of HCA Healthcare in a research report on Friday, April 24th. Argus dropped their target price on shares of HCA Healthcare from $560.00 to $500.00 and set a “buy” rating for the company in a research note on Monday, May 4th. Wells Fargo & Company decreased their price target on shares of HCA Healthcare from $436.00 to $428.00 and set an “equal weight” rating on the stock in a research note on Monday. Finally, TD Cowen reduced their price objective on HCA Healthcare from $500.00 to $431.00 and set a “buy” rating on the stock in a report on Monday, June 22nd. Fourteen analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $496.77.

Check Out Our Latest Research Report on HCA Healthcare

About HCA Healthcare

(Free Report)

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.

See Also

Institutional Ownership by Quarter for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.